Therapeutic vaccines for cancer: an overview of clinical trials. - Wikidata - awgldk - TriplyDB

Therapeutic vaccines for cancer: an overview of clinical trials.

Therapeutic vaccines for cancer: an overview of clinical trials.

http://www.wikidata.org/entity/Q38227030

about

A Perspective of Immunotherapy for Prostate Cancer Immune Cells in Cancer Therapy and Drug Delivery Recent advances of biomaterials in biotherapy Cancer immunotherapy: the beginning of the end of cancer?Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies Alum: an old dog with new tricks Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential RNA-Based Vaccines in Cancer Immunotherapy Engineering opportunities in cancer immunotherapy Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trials Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State The Promise of Preventive Cancer Vaccines Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications The next steps in next-gen sequencing of cancer genomes Immunotherapy in endometrial cancer - an evolving therapeutic paradigm Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site Adjuvants for peptide-based cancer vaccines Harnessing adaptive natural killer cells in cancer immunotherapy Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy Engineering New Approaches to Cancer Vaccines Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma.Designing therapeutic cancer vaccine trials with delayed treatment effect.Trial Watch: Peptide-based anticancer vaccines.Big opportunities for small molecules in immuno-oncology.The present status and future prospects of peptide-based cancer vaccines.Novel immune checkpoint blocker approved for the treatment of advanced melanoma Classification of current anticancer immunotherapies Immunomodulatory spherical nucleic acids.T cell metabolic fitness in antitumor immunity.Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation.Asymptotic dynamics of some t-periodic one-dimensional model with application to prostate cancer immunotherapy.

P2860

Q26741277-7513D532-73E9-436E-9C5F-52219F5CEC4A Q26747061-C60BB442-FBE4-46B2-96A8-AB34D0DBD41E Q26752054-68980590-E37B-4130-A8DA-F655A58E85C7 Q26752277-776B20C6-F315-48BC-AFDA-683D86C3981E Q26752558-1129EAA5-8681-4EFD-8EC7-EE90B32B8717 Q26752643-6BF508E3-3A44-4EC6-ADEB-1F94FF27A578 Q26769884-E8A17F8D-B008-4912-A4B9-59C6421F2012 Q26776028-23824CA1-B402-4253-AC5E-1F8ADEF0D67D Q26776373-F8D707D2-409E-43B8-8ACA-DEC96C69A11C Q26781538-2D5F43B2-B402-4EF5-9A44-AD7D4B844BD5 Q26782566-6F299D01-7861-437B-BF12-7E7AD21FFA84 Q26782573-D09444A4-7249-47E9-844D-281F443F0257 Q26783742-1EB37607-F675-4D1D-9F34-7D89191D8312 Q26783783-293ED4FD-A9A1-4044-AD51-BA79CB5FA65D Q26799574-AFE20E0B-7810-4AAA-AD7E-741682098D3E Q26992272-1FB5A176-3A38-4B76-80C0-CA40AAB605C3 Q26996518-335E0D99-A357-4320-A13D-708B2AACF02D Q26998894-BFECF937-B1FF-401C-BBEF-D98A892FC2FB Q27020910-8D87A8AA-0EB5-4852-8CB6-5BFFBE5B0A9E Q28066935-3D0E38B4-0A2C-48CE-8067-3A72B63154CA Q28072236-44BB4B5A-C9CC-440C-8165-7EE66EBF4C11 Q28081448-4B83C060-4A2A-441A-AF84-7F3049D0246E Q28082487-A44FED55-8169-4E5D-9BE1-DF0B39AB5E6B Q28083766-189E7FCF-A142-4411-B05F-7F5B28C5056A Q28085563-CF3B7D03-8195-443A-8765-73B4FA34CCDF Q30235405-EFC90CFF-99DA-4147-8FB0-8876380EE323 Q33671093-8573F5C5-CF15-4312-91C1-7B3391FCE9A1 Q33772914-53D47BE9-A8B3-409A-9236-41FC72803DCD Q33798098-C3BBDF36-3B2D-4DDB-99A6-29A381C74A6D Q33908263-E1C2FFEC-F749-4F99-BF57-41220DDEF621 Q34483345-7D6A69F6-7251-4B06-97E7-A03DFEA0BF3B Q34487689-C90D8904-DBD9-4188-8ED3-44591968A597 Q34528638-B87CB738-5B88-4EE9-BF81-C5251D297956 Q34936394-B4D13E03-BA72-4859-B896-3A4103ACDFFE Q35149637-A5852DF2-4882-4E08-84E1-F59A53388B6C Q35279697-BC189874-4C03-49A7-86EF-772A5DD24754 Q35371293-839EED66-D792-4E2C-8DA8-4B5ADFA3D7E6 Q35705462-E4E700DE-696D-49B4-9F1D-4B97EFD9FB3E Q35770643-7BD3E6F4-888C-44F8-AEDC-353B3F5FC8BE Q35929337-4BF0DFD5-433D-45FA-8DED-5B3BD6025486

P2860

Therapeutic vaccines for cancer: an overview of clinical trials.

http://www.wikidata.org/entity/Q38227030

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapeutic vaccines for cancer: an overview of clinical trials.

@en

type

label

Therapeutic vaccines for cancer: an overview of clinical trials.

@en

prefLabel

Therapeutic vaccines for cancer: an overview of clinical trials.

@en

P1433

Q38227030-CDBBC05E-12DE-470B-80BC-E505B7BF83FD

P1476

Q38227030-6EB07CCF-7766-444C-AD3A-3C5B6BB9F5BA

P2093

Q38227030-0FDD4B9E-EDE2-41BF-BBEF-55636EFE709B

Q38227030-488E1C6A-F8BB-47E9-902A-0AAE5B3D34E6

Q38227030-495EE1E9-46C9-41FE-8C0E-3E21D62C539F

Q38227030-75F49ADF-19EA-43B7-9CA3-AD3D714AB904

Q38227030-7631A46A-87EA-465C-84D1-F802DD8A2353

Q38227030-A06A1948-CEF1-47A8-B37D-7B8443B70543

Q38227030-DEB820FC-1915-49DD-AE26-8262C832D316

Q38227030-E728486D-00D2-4643-9016-597CC13AB54F

Q38227030-FF96B2E8-843B-4B66-B6A1-C99C1B473695

P2860

Q38227030-00D8F7AB-B219-406D-B91C-9400631FF4B2

Q38227030-01798D36-A0B9-466C-ABBD-55ED41D2DCA4

Q38227030-02D14A72-E1AC-437F-BFFB-442EF070F008

Q38227030-0413AD0F-1483-408B-A30E-EBEA6C6E0EEE

Q38227030-06993086-A4E6-4167-A475-A5E3EFDBB32D

Q38227030-0A66D729-3E65-4FE6-9E50-9BD7D760CFDF

Q38227030-0F2661AF-A631-4931-9F66-0FE78AB91055

Q38227030-0FBADAF9-B30B-4FB4-A70A-9614BFB4B531

Q38227030-127799BD-2CE2-4953-9042-BC1F819FF3E6

Q38227030-1458EA4C-7B80-4247-BEE1-3F2482C7E230

P2888

Q38227030-1592BC21-8B62-48D8-A7F7-688123639B5F

P304

Q38227030-CCFF2C35-1A82-46E8-8832-CD9BD9884EC8

P31

Q38227030-3CE89FE9-C488-4D8F-A946-D978B8EF7F1B

P356

Q38227030-06DC164B-491F-4E4B-A9FB-463952FB3F48

P407

Q38227030-511BD505-C9F5-40DD-AA31-2E787354FCC8

P433

Q38227030-10A5A73C-66C2-4B05-8E90-F753C4632369

P478

Q38227030-99FB1F57-8860-4DCE-A593-D82850584742

P50

Q38227030-2571E2A7-548C-4253-B4F6-66014B4F321E

Q38227030-6BC17E2F-3ABE-4138-B60B-A887943AA895

P577

Q38227030-F02D8DFE-B8C7-401C-9EA7-9E72C2834956

P5875

Q38227030-627ED573-BE94-4CBE-8C32-8431F92FD3DC

P6179

Q38227030-15ABBF19-E7D9-4687-8A31-19BE744A25B2

P698

Q38227030-539A2079-899C-409A-B347-116571346B94

P356

NRCLINONC.2014.111

P1433

Nature Reviews Clinical Oncology

P1476

Therapeutic vaccines for cancer: an overview of clinical trials.

@en

P2093

Christoph Huber

http://www.w3.org/2001/XMLSchema#string

Christoph Zielinski

http://www.w3.org/2001/XMLSchema#string

Giorgio Parmiani

http://www.w3.org/2001/XMLSchema#string

Gustav Gaudernack

http://www.w3.org/2001/XMLSchema#string

Håkan Mellstedt

http://www.w3.org/2001/XMLSchema#string

Ian Faulkner

http://www.w3.org/2001/XMLSchema#string

Ignacio Melero

http://www.w3.org/2001/XMLSchema#string

Nicholas Thatcher

http://www.w3.org/2001/XMLSchema#string

Winald Gerritsen

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

mTOR regulates memory CD8 T-cell differentiation

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2

Nivolumab plus ipilimumab in advanced melanoma.

P2888

nrclinonc.2014.111

P304

509-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2014.111

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263740155

http://www.w3.org/2001/XMLSchema#string

P6179

1044950640

http://www.w3.org/2001/XMLSchema#string

P698

25001465

http://www.w3.org/2001/XMLSchema#string